摘要
尽管大量的抗癌药如今在临床得到使用,因为抗药性而导致的治疗失败是非常频繁的。为了找到防止和避免这样的抵制,鉴定对不同药物的抗药性的作用机制是必要的。的确,新型治疗靶点的识别来克服肿瘤耐药性仍是药物发现和开发中的主要挑战之一。确定耐药性的机制和新型治疗靶点很大程度依赖于肿瘤耐药细胞系的建立。这样一种耐药细胞系的建立过程是艰辛的,耗时的,并且有许多不同的方法报道。这篇综述总结了在肿瘤耐药细胞系创建的方法和耐药机制的鉴定。另外,这篇综述强调了在肿瘤细胞中发现的最频繁的耐药机制
关键词: 获得耐药性,抗癌药物,肿瘤耐药,肿瘤耐药细胞系,同基因细胞系,耐药机制,多重耐药
图形摘要
Current Cancer Drug Targets
Title:Understanding Cancer Drug Resistance by Developing and Studying Resistant Cell Line Models
Volume: 16 Issue: 3
Author(s): Cristina P.R. Xavier, Milica Pesic and M. Helena Vasconcelos
Affiliation:
关键词: 获得耐药性,抗癌药物,肿瘤耐药,肿瘤耐药细胞系,同基因细胞系,耐药机制,多重耐药
摘要: Despite the enormous number of anticancer drugs presently available in the clinic, treatment failure due to drug resistance is very frequent. The identification of mechanisms of resistance to different drugs is necessary, in order to identify ways to prevent and circumvent such resistance. Indeed, the identification of novel therapeutic targets to overcome cancer drug resistance remains one of the major challenges in drug discovery and development. The methods employed to identify drug resistance mechanisms and novel therapeutic targets depend greatly on the establishment of cancer drug resistant cell lines. The establishment of such drug resistant cell lines is laborious and time-consuming and various different approaches have been described. This manuscript reviews the methodologies that have been used to create cancer drug resistant cell lines and to identify their mechanisms of resistance. In addition, this review highlights the most frequent drug resistance mechanisms found in cancer cells.
Export Options
About this article
Cite this article as:
Cristina P.R. Xavier, Milica Pesic and M. Helena Vasconcelos , Understanding Cancer Drug Resistance by Developing and Studying Resistant Cell Line Models, Current Cancer Drug Targets 2016; 16 (3) . https://dx.doi.org/10.2174/1568009616666151113120705
DOI https://dx.doi.org/10.2174/1568009616666151113120705 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting EGFR and HER2 with 211At-Labeled Molecules: Unexpected and Expected Dose-Effect Relations in Cultured Tumor Cells
Current Radiopharmaceuticals Peptide Prodrugs for the Treatment of CNS Disorders: A Perspective for New Drugs
Current Medicinal Chemistry Bridging Indigenous Knowledge and Scientific Evidence for Pharmacological Studies of <i>Phaleria macrocarpa</i>: A Systematic Review
The Natural Products Journal Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors as Therapeutics: Rationales, Controversies, Clinical Experience
Current Drug Targets A Closer Look at α-Secretase
Current Alzheimer Research How to Target Activated Ras Proteins: Direct Inhibition vs. Induced Mislocalization
Mini-Reviews in Medicinal Chemistry Functional Cross-Talk between Adenosine and Metabotropic Glutamate Receptors
Current Neuropharmacology Patent Selections
Recent Patents on Anti-Cancer Drug Discovery Recent Advances in Metabolic Profiling and Imaging of Prostate Cancer
Current Metabolomics Anticancer Effects of Ginsenoside Rh2: A Systematic Review
Current Molecular Pharmacology High Throughput Determination of Gains and Losses of Genetic Material Using High Resolution BAC Arrays and Comparative Genomic Hybridization
Combinatorial Chemistry & High Throughput Screening Apoptosis and Autophagy Induction As Mechanism of Cancer Prevention by Naturally Occurring Dietary Agents
Current Drug Targets The Emerging Role of Metabotropic Glutamate Receptors in the Pathophysiology of Chronic Stress-Related Disorders
Current Neuropharmacology Anti-miRNA-23a Oligonucleotide Suppresses Glioma Cells Growth by Targeting Apoptotic Protease Activating Factor-1
Current Pharmaceutical Design Rational Targeting of the Urokinase Receptor (uPAR): Development of Antagonists and Non-Invasive Imaging Probes
Current Drug Targets Transmembrane Protein 166 and its Significance
Protein & Peptide Letters Curcumin Suppresses Tumor Growth and Angiogenesis in Human Glioma Cells Through Modulation of Vascular Endothelial Growth Factor/ Angiopoietin-2/Thrombospondin-1 Signaling
CNS & Neurological Disorders - Drug Targets Molecular Imaging of Therapeutic Potential of Reporter Probes
Current Drug Targets Current Perspectives in the Application of Medicinal Plants Against Cancer: Novel Therapeutic Agents
Anti-Cancer Agents in Medicinal Chemistry Computational Analysis of miRNA and their Gene Targets Significantly Involved in Colorectal Cancer Progression
MicroRNA